acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 15 Nov 2022 Invitation to presentation of Acarix´s third quarter report 2022 Acarix will publish its third quarter results on Wednesday 16 November 2022 at 08.00 am (CEST). A live webcast will be held at 16.30 (C... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 15 Nov 2022 Inbjudan till presentation av Acarix delårsrapport för tredje kvartalet 2022 Acarix publicerar sin rapport för tredje kvartalet onsdagen den 16 november 2022 kl 08.00. En direktsänd websändning kom... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 28 Sep 2022 Patient enrollment completed in the FILTER-SCAD randomized controlled multi-center trial The FILTER-SCAD study is a randomized controlled clinical trial including more than 2,000 patients with suspected coronary artery disea... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 28 Sep 2022 Patientrekrytering slutförd för den randomiserade kontrollerade multicenterstudien FILTER-SCAD FILTER-SCAD-studien är en randomiserad kontrollerad klinisk prövning med fler än 2 000 patienter med misstänkta kra... Continue reading
acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 26 Sep 2022 Acarix and the American College of Cardiology announce strategic collaboration The American College of Cardiology (“ACC”) and Acarix have signed a strategic collaboration agreement with the goal to deve... Continue reading
acarix Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish November 18, 2024 26 Sep 2022 Acarix och American College of Cardiology tecknar strategiskt samarbete American College of Cardiology (“ACC”) och Acarix har tecknat ett strategiskt samarbetsavtal med syfte att utveckla ett kli... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 22 Sep 2022 Acarix presents at the Redeye event, Theme: Diagnostics On September 27 at 11.30 am CEST, Helen Ljungdahl Round, President and CEO at Acarix will present the company´s latest developmen... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 22 Sep 2022 Acarix presenterar på Redeye under temat Diagnostik Den 27 september kl 11.30 kommer Helen Ljungdahl Round, VD på Acarix, att presentera bolagets senaste utveckling inom DiagnostikP... Continue reading
acarix English, Interim, IR, Listing Regulation, News, Q2, Regulatory, Report November 18, 2024 25 Aug 2022 Acarix AB (publ) publishes Interim Report, January – June 2022 Significant interest and positive developments in the US marketWe can now conclude that our Go-To-Market strategy in the USA has starte... Continue reading
acarix Interim, IR, Listing Regulation, News, Q2, Regulatory, Report, Swedish November 18, 2024 25 Aug 2022 Acarix AB (publ) publicerar delårsrapport, januari – juni 2022 Stort intresse och positiv utveckling på den amerikanska marknadenVi kan nu konstatera att vår Go-To-Market strategi i USA ... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 22 Aug 2022 Invitation to presentation of Acarix´s second quarter report Acarix will publish its second quarter results on Thursday 25 August 2022 at 08.00 am (CEST). A live webcast will be held at 14.00 (CES... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 22 Aug 2022 Inbjudan till presentation av Acarix delårsrapport för andra kvartalet Acarix publicerar sin rapport för andra kvartalet torsdagen den 25 augusti 2022 kl 08.00. En direktsänd websändning h&ar... Continue reading